Xeris Biopharma Holdings Inc. (XERS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Xeris Biopharma Holdings Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$10.64
+1.82% today
Market cap
$1.9B
Overall quality
—
Kronos AI 30-day
−28.0%
0 of 8 simulated paths end higher
Xeris Biopharma Holdings Inc. (XERS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.9B. It trades at $10.64, up 1.82% today. 5 analysts' average target of $13.00 implies +22.2% from today's price. Kronos AI's 30-day forecast is −28.0% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $13.00 |
| Low – high | $8.00 – $18.00 |
| Analysts | 5 |
| Upside to average | +22.2% |
Kronos AI 30-day forecast
| Expected close | $7.53 (−28.0%) |
| Likely range | −32.9% … −22.3% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.